The Food and Drug Administration (FDA) is not putting up with skin care companies that make outlandish claims about their products. The agency issued a warning letter to California-based Circuit Cosmeceuticals Inc., saying the company cannot make claims about the effectiveness of its anti-aging creams unless they were approved drugs.
Sircuit claims that its Revelation eye serum “resembles the effects of Botox when applied to the skin” and “gives Botox-like results.” It also claimed that its Eye Tech emulsion can “impart Botox-like effect.” The company alleged that its products could stimulate collagen production, help blood vessels operate properly, and strengthen the immune system and active white blood cells. Some of its products also reportedly “can be considered an effective alternative to collagen injections.”
Botox and collagen injections are treatments that can only be administered by health care professionals. They are also listed as drug ingredients, meaning that they have undergone testing to evaluate their safety and efficacy.
The FDA says if the company wants to promote it products as medical treatments, it needs to pony up evidence to support the claims it is making. Otherwise, “your products are not generally recognized as safe and effective,” the FDA wrote in its warning letter.
The agency gave the company 15 days to correct the violations with its products. Failure to do so may result in enforcement action without further notice.” It could also result in injunctions against the manufacturers and distributors and seizure of products.